rs2189883

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.2383+13806G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.643 in 151,922 control chromosomes in the GnomAD database, including 33,737 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.64 ( 33737 hom., cov: 31)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.201

Publications

6 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.885 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.2383+13806G>A intron_variant Intron 15 of 23 ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.2383+13806G>A intron_variant Intron 15 of 23 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1
CNTNAP2ENST00000627772.2 linkn.556+13806G>A intron_variant Intron 4 of 12 2
CNTNAP2ENST00000636870.1 linkn.2245+13806G>A intron_variant Intron 13 of 21 5
CNTNAP2ENST00000637825.1 linkn.1866+13806G>A intron_variant Intron 12 of 13 5

Frequencies

GnomAD3 genomes
AF:
0.643
AC:
97544
AN:
151804
Hom.:
33670
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.893
Gnomad AMI
AF:
0.372
Gnomad AMR
AF:
0.669
Gnomad ASJ
AF:
0.382
Gnomad EAS
AF:
0.833
Gnomad SAS
AF:
0.498
Gnomad FIN
AF:
0.623
Gnomad MID
AF:
0.369
Gnomad NFE
AF:
0.503
Gnomad OTH
AF:
0.576
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.643
AC:
97676
AN:
151922
Hom.:
33737
Cov.:
31
AF XY:
0.646
AC XY:
47949
AN XY:
74204
show subpopulations
African (AFR)
AF:
0.893
AC:
37057
AN:
41492
American (AMR)
AF:
0.670
AC:
10212
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.382
AC:
1323
AN:
3466
East Asian (EAS)
AF:
0.833
AC:
4292
AN:
5152
South Asian (SAS)
AF:
0.498
AC:
2396
AN:
4816
European-Finnish (FIN)
AF:
0.623
AC:
6549
AN:
10518
Middle Eastern (MID)
AF:
0.380
AC:
111
AN:
292
European-Non Finnish (NFE)
AF:
0.503
AC:
34184
AN:
67916
Other (OTH)
AF:
0.575
AC:
1214
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1577
3154
4732
6309
7886
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
756
1512
2268
3024
3780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.540
Hom.:
12944
Bravo
AF:
0.662
Asia WGS
AF:
0.663
AC:
2301
AN:
3472

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
3.1
DANN
Benign
0.55
PhyloP100
0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2189883; hg19: chr7-147688887; API